Aviva PLC Amgen Inc Transaction History

Aviva PLC

$34.3 Billion
Q2 2024

A detailed history of Aviva PLC transactions in Amgen Inc stock. As of the latest transaction made, Aviva PLC holds 325,771 shares of AMGN stock, worth $103 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

325,771

Previous 255,460 27.52%

Holding current value

$103 Million

Previous $72.6 Million 40.14%

% of portfolio

0.3%

Previous 0.26%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$262.75 - $319.31 $18.5 Million - $22.5 Million	70,311 Added 27.52%	325,771 $102 Million
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $3.09 Million - $3.73 Million	11,503 Added 4.72%	255,460 $72.6 Million
Q4 2023 Feb 09, 2024	BUY	$255.7 - $288.46 $10.1 Million - $11.4 Million	39,486 Added 19.31%	243,957 $70.3 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $1.52 Million - $1.89 Million	6,960 Added 3.52%	204,471 $55 Million
Q2 2023 Aug 10, 2023	BUY	$214.27 - $253.37 $9.87 Million - $11.7 Million	46,084 Added 30.43%	197,511 $43.9 Million
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $7.21 Million - $8.78 Million	-31,917 Reduced 17.41%	151,427 $36.6 Million
Q4 2022 Feb 09, 2023	BUY	$229.03 - $291.01 $5.8 Million - $7.38 Million	25,344 Added 16.04%	183,344 $48.2 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $7.92 Million - $8.93 Million	-35,273 Reduced 18.25%	158,000 $35.6 Million
Q2 2022 Aug 04, 2022	BUY	$230.71 - $256.74 $3.51 Million - $3.9 Million	15,208 Added 8.54%	193,273 $47 Million
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $1.32 Million - $1.46 Million	-6,026 Reduced 3.27%	178,065 $43.1 Million
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $1.71 Million - $1.96 Million	8,596 Added 4.9%	184,091 $41.4 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $4.97 Million - $5.82 Million	-23,391 Reduced 11.76%	175,495 $37.3 Million
Q2 2021 Aug 10, 2021	SELL	$233.58 - $259.14 $2.4 Million - $2.67 Million	-10,296 Reduced 4.92%	198,886 $48.5 Million
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $332,421 - $387,382	-1,498 Reduced 0.71%	209,182 $52 Million
Q4 2020 Feb 10, 2021	BUY	$216.38 - $257.67 $966,136 - $1.15 Million	4,465 Added 2.17%	210,680 $48.4 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $1.87 Million - $2.08 Million	-7,968 Reduced 3.72%	206,215 $52.4 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $1.69 Million - $2.07 Million	-8,525 Reduced 3.83%	214,183 $50.5 Million
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $1.88 Million - $2.49 Million	10,321 Added 4.86%	222,708 $45.2 Million
Q4 2019 Feb 10, 2020	SELL	$189.21 - $243.2 $894,017 - $1.15 Million	-4,725 Reduced 2.18%	212,387 $51.2 Million
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $1.59 Million - $1.91 Million	-9,149 Reduced 4.04%	217,112 $42 Million
Q2 2019 Jul 30, 2019	SELL	$166.7 - $195.41 $9.69 Million - $11.4 Million	-58,110 Reduced 20.43%	226,261 $41.7 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $9.84 Million - $11.1 Million	-54,389 Reduced 16.06%	284,371 $54 Million
Q4 2018 Feb 12, 2019	SELL	$178.4 - $208.25 $13.9 Million - $16.2 Million	-77,808 Reduced 18.68%	338,760 $65.9 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $4 Million - $4.51 Million	-21,567 Reduced 4.92%	416,568 $86.4 Million
Q2 2018 Aug 01, 2018	SELL	$166.05 - $186.51 $5.96 Million - $6.69 Million	-35,863 Reduced 7.57%	438,135 $80.9 Million
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $11.6 Million - $13.5 Million	-68,255 Reduced 12.59%	473,998 $80.8 Million
Q4 2017 Feb 13, 2018	SELL	$168.79 - $188.59 $10.6 Million - $11.8 Million	-62,608 Reduced 10.35%	542,253 $94.3 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $118,943 - $135,801	711 Added 0.12%	604,861 $113 Million
Q2 2017 Aug 07, 2017	BUY	N/A	604,150	604,150 $104 Million

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.

Account